Overview

Proteomics Market is poised to value over USD 61.9 billion by 2027 end at a CAGR of over 16.5% during the forecast period 2020 to 2027.

The study of the functions and structure of proteins used in drug diagnosis, treatment and discovery of diseases. A proteome is unstable as it is different from cell to cell It is used for the evaluation of the protein production rate, protein interaction, proteins involvement in pathways of the metabolic system, and protein modification. The usage of structural proteomics in identifying the complex protein structure, whereas the functional proteomics is utilized for protein‐protein characteristic interactions in order to demonstrate the functions of the protein.

Proteomics finds in-deep applications in identifying markers for disease diagnosis and drug development and discovery of personalized medicines, which have accelerated the global market in recent years. With growing awareness pertaining to the advantages of personalized medicines, government organizations and companies have increased their expenditure of research and development on developing proteomics.

The global market is predicted to proliferate at a substantial rate over the forecast period, due to personalized medicines getting increasingly popular, soaring expenditure on the research and development and advancements in technology related to proteomics. Moreover, a rise in the availability and awareness of proteomics instruments in developing as well as developed market escalates the market augmentation. Nonetheless, high proteomics component costs and a lack of skilled healthcare professionals in the global proteomics industry hamper the overall market growth. Conversely, profitable opportunities pertaining to the identification of biomarkers and developing mass proteomics based on spectrometry are predicted to offer numerous opportunities for growth to the key players.

The analysis of the global proteomics market size is performed using the component vertical in the report. The component segment accounted for the largest global proteomics market share in 2018, and it is projected to maintain its dominance over the forecast period due to reagents being an integral part of the components of proteomics. The reagents are utilized as a binding material and precursor of chemical reactions during protein structure characterization and analysis. Furthermore, fundamental protocols of proteomics need reagents, which is why this segment is anticipated to occupy the largest market share in the component segment throughout the forecast period.

Major players included in the Proteomics Market:
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• Agilent Technologies, Inc.
• Bruker Corporation
• Danaher Corporation
• GE Healthcare
• Luminex Corporation
• PerkinElmer Inc.
• Waters Corporation
• Illumina, Inc.
• Eurofins Scientific
• QIAGEN Bioinformatics
• Creative Proteomics
• Promega Corporation
• Sengenics
• Biomax Informatics AG
• MS Bioworks LLC
• WuXi NextCODE
• Fios Genomics Ltd.
(Note: The list of the major players will be updated with the latest market scenario and trends)

Bruker Corporation announced a wide line up of products of mass spectrometry and workflows at the American Society for Mass Spectrometry conference in June 2018. Similarly, ThermoFisher Scientific, Inc. announced iXR Raman Spectrometer in March 2017. This product was manufactured for accurate and rapid structural and chemical analysis. Moreover, Waters Corp. initiated the BioAccord System in January 2019, which is a solution of liquid chromatography-mass spectrometry (LC-MS) that is predicted to extend availability to time-of-flight, high-resolution capabilities of mass spectrometry to more scientists. A considerable rise has been showcased in the collaborations and acquisitions in the global market.

Proteomics Market Segmentation:
By Instrumentation Technology

• Spectroscopy
o Mass Spectroscopy
o NMR Spectroscopy
o CD Spectroscopy
• Chromatography
o HPLC
o Ion Chromatography
o Affinity Chromatography
o Supercritical Fluid Chromatography
• Electrophoresis
o Gel Electrophoresis
o Capillary Electrophoresis
• Protein Microarrays
o Biochips
• Lab-on-Chips
• Protein Chips
o Micrparray Instruments
• Integrated Systems
• Microarray Scanners
• Arrayers
• X – Ray Crystallography
• Surface Plasmon Resonance
• Protein Fractionation

By Reagent
• Immunoassay Reagents
• Spectroscopy Reagents
• Chromatography Reagents
• Protein Microarray Reagents
• X – Ray Crystallography Reagents
• Electrophoresis Reagents
• Protein Fractionation Reagents

By Software & Service
• Core Proteomics Services
o Protein Identification Services
o Protein Characterization Services
o Quantitative Proteomic Services
o Protein Purification Services
o Protein Sequencing Services
o Custom Assay Services
• Bioinformatics Software & Services
o Bioinformatics Software
o Bioinformatics Tools
o Bioinformatics Databases

By Application
• Clinical Diagnostics
o Cancer
o Infectious Diseases
o Diabetes
o Neurological Disorders
o Immune Diseases
o Cardiovascular Diseases
o Other Clinical Diagnostic Applications
• Drug Discovery
o Target Discovery
o Lead Identification
o Lead Optimization
o Preclinical Studies
• Other Application

By End User
• Hospitals
• Clinical Laboratories
• Pharmaceutical Companies
• Academic Research Laboratories
• Other End Users

By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Proteomics Market By Instrumentation Technology, By Reagent, By Software & Service, By Application, By End User and By Region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com